ACXP · Acurx Pharmaceuticals, Inc. · Investor Relations
$1.31
+0.00 (+0.00%)
At close · Oct 6
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result, our independent registered public accounting firm has expressed substantial doubt about our ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.”View the 10-Q filed Aug 13, 2026
Market Cap
$7.09M
Shares
5.27M
Volume · Oct 6
42.2K
Avg daily vol (3M)
127.38K
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Upcoming events
| Date | Event | Type |
|---|---|---|
| 2026-10-16 14:00 UTC | 2026 Annual Meeting of Stockholders | Shareholder meeting |
Past events
| Date | Event | Type |
|---|---|---|
| 2026-08-14 | Second Quarter Financial Results Conference Call | Earnings call |
| 2026-07-10 | 18th Biennial Congress of the Anaerobe Society of the Americas | Event |
| 2026-05-21 | 35th Congress of ESCMID Global | Event |
| 2026-05-20 | Alliance Global Partners (A.G.P) Healthcare Company Showcase | Event |
| 2026-05-12 | First Quarter Financial Results Conference Call | Earnings call |
| 2026-03-13 | Fourth Quarter Financial Results Conference Call | Earnings call |
Source: https://ir.acurxpharma.com/